Clinical Trials on HER2 Expressing or Mutated Advanced Malignant Solid Tumors in United States
Total 296 results
-
Advaxis, Inc.CompletedHER2 Expressing Solid TumorsUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Fore BiotherapeuticsActive, not recruitingAdvanced Unresectable Solid Tumors | BRAF-mutated TumorsUnited States
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Aadi Bioscience, Inc.RecruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmKorea, Republic of, United States, Puerto Rico
-
PharmaMarCompletedAdvanced Malignant Solid TumorsSpain, United States
-
PfizerRoswell Park Cancer Institute; South Texas Accelerated Research Therapeutics...CompletedAdvanced Malignant Solid TumorsUnited States
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Malignant Solid TumorsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Malignant Solid TumorUnited States, Japan
-
BioNTech SEGenmabRecruitingAdvanced Malignant Solid TumorUnited States, United Kingdom
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Advanced Integrative Medical Science InstituteRecruitingNeoplasms | Advanced Solid Tumor | Advanced Cancer | Oncology | Neoplasm MalignantUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Syndax PharmaceuticalsCompletedSolid Tumor | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | Metastatic TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | HER2-Positive Breast CarcinomaUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
NewLink Genetics CorporationTerminatedAdvanced Solid Tumor MalignancyUnited States
-
Synta Pharmaceuticals Corp.CompletedAdvanced or Metastatic Solid TumorsUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Ovarian Carcinoma | Pancreatic Neuroendocrine Tumor | Unresectable Solid Neoplasm | Fibrolamellar CarcinomaUnited States
-
Sameek RoychowdhuryNational Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ALK Gene Mutation | Metastatic Malignant Neoplasm in the Brain | Advanced Malignant Neoplasm | ALK Fusion Protein Expression | Metastatic Malignant Neoplasm in the Central Nervous System | ROS1 Gene Mutation | ALK Gene... and other conditionsUnited States
-
Incendia TherapeuticsRecruitingAdvanced or Metastatic Solid TumorsUnited States
-
PfizerCompletedA Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors (CVX-045-101)Neoplasms | Carcinoma | Cancer | Advanced Solid Tumors | MalignancyUnited States
-
DynamiCure BiotechnologyTerminatedAdvanced or Metastatic Solid TumorsUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
Erasca, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States
-
Bien-Willner Physicians Group PANo One Left Alone; Carolina Blood and Cancer Care AssociatesNot yet recruitingAdvanced Cancer | Myeloid Malignancy | Solid Tumor, AdultUnited States
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
PfizerCompletedNeoplasms | Carcinoma | Cancer | Advanced Solid Tumors | MalignancyUnited States
-
SynDevRx, Inc.CompletedAdvanced Solid Tumors | Metastasis | Neoplasm | Advanced MalignancyUnited States
-
Avistone Biotechnology Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Aptose Biosciences Inc.CompletedAdvanced or Metastatic Solid TumoursUnited States
-
Hanmi Pharmaceutical Company LimitedRecruitingAdvanced or Metastatic Solid TumorsKorea, Republic of, United States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedLocally Advanced or Metastatic Solid TumorsUnited States, United Kingdom
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, China
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
Tallac TherapeuticsRecruitingAdvanced or Metastatic Solid TumorsUnited States, Australia
-
DynamiCure BiotechnologyRecruitingAdvanced or Metastatic Solid TumorsUnited States, Australia
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Chugai PharmaceuticalRecruitingLocally Advanced or Metastatic Solid TumorsUnited States, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada, Spain
-
National Cancer Institute (NCI)CompletedBreast Cancer | Breast Neoplasms | Adenocarcinomas | Metastatic Solid Tumors Characterized by HER2/Neu ExpressionUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerUnited States